Is There a Need for Cholesteryl Ester Transfer Protein Inhibition?
- 1 March 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (3) , 374-375
- https://doi.org/10.1161/01.atv.0000060447.25136.1c
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Cholesteryl Ester Transfer ProteinArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemiaClinical Science, 2002
- Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out MicePublished by Elsevier ,2002
- Human Apolipoprotein C-I Accounts for the Ability of Plasma High Density Lipoproteins to Inhibit the Cholesteryl Ester Transfer Protein ActivityPublished by Elsevier ,2000
- A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbitsNature, 2000
- Unraveling the mysteries of high density lipoprotein metabolismCurrent Opinion in Lipidology, 1999
- Molecular Cloning and Expression of Lipid Transfer Inhibitor Protein Reveals Its Identity with Apolipoprotein FPublished by Elsevier ,1999
- Large and Cholesteryl Ester-Rich High-Density Lipoproteins in Cholesteryl Ester Transfer Protein (CETP) Deficiency Can Not Protect Macrophages from Cholesterol Accumulation Induced by Acetylated Low-Density Lipoproteins1The Journal of Biochemistry, 1994
- Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins.Journal of Clinical Investigation, 1991
- Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese MenNew England Journal of Medicine, 1976